Discovery of a Streptococcus pneumoniae serotype 33F capsular polysaccharide locus that lacks wcjE and contains a wcyO pseudogene

PLoS One. 2018 Nov 5;13(11):e0206622. doi: 10.1371/journal.pone.0206622. eCollection 2018.

Abstract

As part of large on-going vaccine impact studies in Fiji and Mongolia, we identified 25/2750 (0.9%) of nasopharyngeal swabs by microarray that were positive for Streptococcus pneumoniae contained pneumococci with a divergent 33F capsular polysaccharide locus (designated '33F-1'). We investigated the 33F-1 capsular polysaccharide locus to better understand the genetic variation and its potential impact on serotyping results. Whole genome sequencing was conducted on ten 33F-1 pneumococcal isolates. Initially, sequence reads were used for molecular serotyping by PneumoCaT. Phenotypic typing of 33F-1 isolates was then performed using the Quellung reaction and latex agglutination. Genome assemblies were used in phylogenetic analyses of each gene in the capsular locus to investigate genetic divergence. All ten pneumococcal isolates with the 33F-1 cps locus typed as 33F by Quellung and latex agglutination. Unlike the reference 33F capsule locus sequence, DNA microarray and PneumoCaT analyses found that 33F-1 pneumococci lack the wcjE gene, and instead contain wcyO with a frameshift mutation. Phylogenetic analyses found the wzg, wzh, wzd, wze, wchA, wciG and glf genes in the 33F-1 cps locus had higher DNA sequence similarity to homologues from other serotypes than to the 33F reference sequence. We have discovered a novel genetic variant of serotype 33F, which lacks wcjE and contains a wcyO pseudogene. This finding adds to the understanding of molecular epidemiology of pneumococcal serotype diversity, which is poorly understood in low and middle-income countries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amino Acid Sequence
  • Bacterial Capsules / genetics*
  • Base Sequence
  • Child
  • Child, Preschool
  • Fiji / epidemiology
  • Frameshift Mutation
  • Genes, Bacterial*
  • Genetic Variation
  • Genome, Bacterial
  • Humans
  • Infant
  • Molecular Epidemiology
  • Mongolia / epidemiology
  • Pneumococcal Infections / epidemiology
  • Pneumococcal Infections / microbiology
  • Pneumococcal Infections / prevention & control
  • Pneumococcal Vaccines / genetics
  • Polysaccharides, Bacterial / genetics*
  • Pseudogenes
  • Sequence Analysis, DNA
  • Serogroup
  • Serotyping
  • Streptococcus pneumoniae / classification*
  • Streptococcus pneumoniae / genetics*
  • Whole Genome Sequencing

Substances

  • Pneumococcal Vaccines
  • Polysaccharides, Bacterial
  • capsular polysaccharide 33F

Grants and funding

This study was supported by the Bill & Melinda Gates Foundation (OPP1126272 and OPP1084341); Gavi, the Vaccine Alliance; and the Department of Foreign Affairs and Trade of the Australian Government and Fiji Health Sector Support Program (FHSSP). CS holds a NHMRC Career Development Fellowship and a veski Inspiring Women Fellowship. SM received a Robert Austrian Research Award in Pneumococcal Vaccinology funded by Pfizer. This work was also supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.